
Researchers in Australia have discovered an antibody that has helped some people develop immunity against hepatitis C, and they hope to use the discovery as the foundation for an HCV vaccine, Agence France-Presse reports. The study of 160 inmates showed that four Australian prisoners had built up a natural immunity to HCV despite repeated exposures to the virus through injection-drug use. Blood tests showed that even when infected with the virus, the prisoners quickly cleared all HCV from their bodies. A separate study of visitors to a Sydney drop-in center for injection-drug users confirmed the researchers' findings.
"It seems that the higher the risk behavior, the greater the likelihood the immunity would be present," lead researcher Andrew Lloyd of the University of New South Wales told Agence France-Presse. "I suspect it has something to do with the circumstances of the first exposure. It may be that it was a very low dose that gets into the body and pushes the balance in favor of an immune response."
The researchers say a build-up of a naturally occurring antibody that can cripple the virus causes the immunity. Lloyd says his group's findings appear to be similar to those of a study of Kenyan sex workers repeatedly exposed to HIV, but who were able to avoid contracting the disease. Lloyd says his team and other scientists are now working on artificially replicating the naturally occurring antibody for use in a possible vaccine to prevent HCV infection.
The full study appears in the August Journal of Infectious Diseases.
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
Comments that do not concern specific articles in The Advocate or on Advocate.com will not be posted or published. See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.